As of 2026-06-18, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (25.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -3608478.7%.
The range of the Relative Valuation is (23.85) - (28.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 21.2x | 17.5x |
| Forward P/E multiples | 16.9x - 20.5x | 18.8x |
| Fair Price | (23.85) - (28.50) | (25.26) |
| Upside | -3407681.9% - -4071703.1% | -3608478.7% |
| Date | P/E |
| 2026-06-16 | -0.00 |
| 2026-06-15 | -0.00 |
| 2026-06-12 | -0.00 |
| 2026-06-11 | -0.00 |
| 2026-06-10 | -0.00 |
| 2026-06-09 | -0.00 |
| 2026-06-08 | -0.00 |
| 2026-06-05 | -0.00 |
| 2026-06-04 | -0.00 |
| 2026-06-03 | -0.00 |
| 2026-06-02 | -0.00 |
| 2026-06-01 | -0.00 |
| 2026-05-29 | -0.00 |
| 2026-05-28 | -0.00 |
| 2026-05-27 | -0.00 |
| 2026-05-26 | -0.00 |
| 2026-05-22 | -0.00 |
| 2026-05-21 | -0.00 |
| 2026-05-20 | -0.00 |
| 2026-05-19 | -0.00 |
| 2026-05-18 | -0.00 |
| 2026-05-15 | -0.00 |
| 2026-05-14 | -0.00 |
| 2026-05-13 | -0.00 |
| 2026-05-12 | -0.00 |
| 2026-05-11 | -0.00 |
| 2026-05-08 | -0.00 |
| 2026-05-07 | -0.00 |
| 2026-05-06 | -0.00 |
| 2026-05-05 | -0.00 |
| 2026-05-04 | -0.00 |
| 2026-05-01 | -0.00 |
| 2026-04-30 | -0.00 |
| 2026-04-29 | -0.00 |
| 2026-04-28 | -0.00 |
| 2026-04-27 | -0.00 |
| 2026-04-24 | -0.00 |
| 2026-04-23 | -0.00 |
| 2026-04-22 | -0.00 |
| 2026-04-21 | -0.00 |
| 2026-04-20 | -0.00 |
| 2026-04-17 | -0.00 |
| 2026-04-16 | -0.00 |
| 2026-04-15 | -0.00 |
| 2026-04-14 | -0.00 |
| 2026-04-13 | -0.00 |
| 2026-04-10 | -0.00 |
| 2026-04-09 | -0.00 |
| 2026-04-08 | -0.00 |
| 2026-04-07 | -0.00 |